Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 7 (July)

1. Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study.
   Neurology, 69(1): 32-41. [Abstract] [Full-text]
2. Environmental and dietary risk factors in Alzheimer's disease.
   Expert Rev Neurother, 7(7): 887-900. [Abstract] [Full-text]
3. Psychometric properties of the German "Pain Assessment in Advanced Dementia Scale" (PAINAD-G) in nursing home residents.
   J Am Med Dir Assoc, 8(6): 388-95. [Abstract] [Full-text]
4. Neuropathological findings processed by artificial neural networks (ANNs) can perfectly distinguish Alzheimer's patients from controls in the Nun Study.
   BMC Neurol, 7: 15. [Abstract] [Full-text]
5. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?
   Neurology, 69(2): 133-9. [Abstract] [Full-text]
6. Cross-species microarray analysis with the OSCAR system suggests an INSR->Pax6->NQO1 neuro-protective pathway in aging and Alzheimer's disease.
   Nucleic Acids Res, 35: W105-14. [Abstract] [Full-text]
7. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
   Bioorg Med Chem, 15(17): 5775-86. [Abstract] [Full-text]
8. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease.
   Neurology, 69(3): 283-90. [Abstract] [Full-text]
9. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
   J Mol Biol, 371(2): 481-9. [Abstract] [Full-text]
10. Rationale for transdermal drug administration in Alzheimer disease.
    Neurology, 69(4): S4-9. [Abstract] [Full-text]
11. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
    Neurology, 69(4): S23-8. [Abstract] [Full-text]
12. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Neurology, 69(4): S14-22. [Abstract] [Full-text]
13. Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
    Neurobiol Aging, 28(9): 1374-80. [Abstract] [Full-text]
14. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging, 28(9): 1330-9. [Abstract] [Full-text]
15. EEG and MRI correlates of mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging, 28(9): 1322-9. [Abstract] [Full-text]
16. Autonoetic consciousness in Alzheimer's disease: neuropsychological and PET findings using an episodic learning and recognition task.
    Neurobiol Aging, 28(9): 1410-20. [Abstract] [Full-text]
17. Alzheimer' s disease, oxidative stress and gammahydroxybutyrate.
    Neurobiol Aging, 28(9): 1340-60. [Abstract] [Full-text]
18. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
    Neurobiol Aging, 28(9): 1381-7. [Abstract] [Full-text]
19. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Neurology, 69(5): 459-69. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.